Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy-Reference-Cited by-同舟云学术

Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy

Published:2020-05-12 Issue:9 Volume:196 Page:813-820
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Nicosia Luca^ORCID,Cuccia Francesco,Mazzola Rosario,Ricchetti Francesco,Figlia Vanessa,Giaj-Levra Niccolò,Rigo Michele,Tomasini Davide,Pasinetti Nadia,Corradini Stefanie,Ruggieri Ruggero,Alongi Filippo

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s00066-020-01627-7.pdf

Reference42 articles.

1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29

2. Elias D, Liberale G, Vernerey D et al (2005) Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 12:900–909

3. Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, Mulroy L, Lock M, Rodrigues GB, Yaremko BP, Schellenberg D, Ahmad B, Griffioen G, Senthi S, Swaminath A, Kopek N, Liu M, Moore K, Currie S, Bauman GS, Warner A, Senan S (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 393(10185):2051–2058. https://doi.org/10.1016/S0140-6736(18)32487-5

4. Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, Dingemans AC, Fournier B, Hurkmans C, Lecouvet FE, Meattini I, Méndez Romero A, Ricardi U, Russell NS, Schanne DH, Scorsetti M, Tombal B, Verellen D, Verfaillie C, Ost P (2020) Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol 21(1):e18–e28. https://doi.org/10.1016/S1470-2045(19)30718-1

5. Alongi F, Arcangeli S, Filippi AR, Ricardi U, Scorsetti M (2012) Review and uses of stereotactic body radiation therapy for oligometastases. Oncologist 17(8):1100–1107. https://doi.org/10.1634/theoncologist.2012-0092

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic body radiation therapy in non-liver colorectal metastases: a scoping review;Journal of Gastrointestinal Oncology;2024-08

2. A retrospective study comparing the efficacy of microwave ablation and stereotactic body radiotherapy in colorectal cancer lung metastases;Oncology Letters;2024-05-14

3. Stereotactic body radiotherapy takes on Lung Oligometastases: Latest breakthroughs;Precision Radiation Oncology;2024-05-09

4. The Clinical Efficacy of Colorectal Cancer Patients with Pulmonary Oligometastases by Sterotactic Body Ablative Radiotherapy: A Meta-Analysis;Cancer Research and Treatment;2023-12-14

5. Stereotactic radiotherapy in the management of oligometastatic and recurrent head and neck cancer: a single-center experience;Strahlentherapie und Onkologie;2023-12-08